cobalt has been researched along with Cirrhosis in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (69.23) | 24.3611 |
2020's | 4 (30.77) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Chi, Z; Li, Q; Liu, YW; Mao, J; Min, S; Zhang, C | 1 |
Packer, M | 1 |
Geng, X; Hu, J; Lai, X; Tan, L; Wang, S | 1 |
Guo, C; Li, X; Li, Z; Qian, Y; Wang, Z; Wei, Y; Xue, K | 1 |
Chaurand, P; Ibouraadaten, S; Lison, D; Marbaix, E; Palmai-Pallag, M; Poleunis, C; Reylandt, L; Rose, J; Sironval, V; Ucakar, B; van den Brule, S; Vanbever, R; Yakoub, Y | 1 |
Gavara, N; Knight, MM; Li, W; Nyga, A; Shelton, JC; Xu, J; Zhang, X | 1 |
Deng, X; Geng, X; Hu, J; Lai, X; Li, A; Li, J; Liu, Y; Qiu, M; Tan, L; Yu, M; Zeng, T; Zhang, M; Zhou, G | 1 |
Chang, LR; Chen, JA; Chou, TM; Chu, CH; Hsu, TI; Huang, JS; Huang, PW; Jeng, SF; Jou, IM; Kuo, YL | 1 |
Amitani, R; Ariyasu, R; Hanaoka, K; Nagano, H; Nakagawa, K; Nakamura, Y; Nishizaka, Y; Okamoto, N; Taki, M; Wakayama, T; Yoshida, M; Yoshimura, C | 1 |
Mihalko, WM; Rider, CM; Wodowski, AJ | 1 |
Chu, S; Xu, H; Zeng, F; Zhang, M | 1 |
Hu, J; Li, A; Li, M; Tan, L; Tang, L | 1 |
Bo, H; Cao, C; Chen, W; Li, X; Liu, L; Wan, X; Yin, Z; Zhao, Y | 1 |
1 review(s) available for cobalt and Cirrhosis
Article | Year |
---|---|
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Topics: Basic Helix-Loop-Helix Transcription Factors; Cobalt; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Erythropoiesis; Fibrosis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Kidney; Oxidative Stress; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
12 other study(ies) available for cobalt and Cirrhosis
Article | Year |
---|---|
CoCl
Topics: Bone Morphogenetic Protein 2; Cell Hypoxia; Cells, Cultured; Cobalt; Fibroblasts; Fibrosis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Myringosclerosis; Osteogenesis; Vimentin | 2022 |
A pH-Responsive System Based on Fluorescence Enhanced Gold Nanoparticles for Renal Targeting Drug Delivery and Fibrosis Therapy.
Topics: Animals; Cell Line; Cobalt; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fibrosis; Fluorescence; Glutathione; Gold; Hydrogen-Ion Concentration; Kidney; Kidney Diseases; Metal Nanoparticles; Mice, Inbred BALB C; Mononuclear Phagocyte System; Rats; Ureteral Obstruction | 2020 |
Cobalt exposure increases the risk of fibrosis of people living near E‑waste recycling area.
Topics: Air Pollution; Cadmium; Cobalt; Copper; Electronic Waste; Environmental Exposure; Fibrosis; Humans; Malondialdehyde; Mercury; Metals, Heavy; Nickel; Oxidative Stress; Recycling; Zinc | 2021 |
Respiratory hazard of Li-ion battery components: elective toxicity of lithium cobalt oxide (LiCoO
Topics: Administration, Inhalation; Air Pollutants; Animals; Biological Availability; Bronchoalveolar Lavage Fluid; Cobalt; Electric Power Supplies; Female; Fibrosis; Iron; Lithium; Lung; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Oxides; Particle Size; Pneumonia; Titanium; Toxicity Tests | 2018 |
Cobalt ions stimulate a fibrotic response through matrix remodelling, fibroblast contraction and release of pro-fibrotic signals from macrophages.
Topics: Adult; Animals; Biomechanical Phenomena; Cell Proliferation; Cell Survival; Chromium; Cobalt; Collagen; Dermis; Extracellular Matrix; Fibroblasts; Fibrosis; Gels; Humans; Ions; Macrophages; Rats; Reactive Oxygen Species | 2018 |
A stimuli-responsive drug release nanoplatform for kidney-specific anti-fibrosis treatment.
Topics: Animals; Cells, Cultured; Cobalt; Drug Liberation; Fibrosis; Gold; Hydrogen-Ion Concentration; Kidney Diseases; Metal Nanoparticles; Optical Imaging; Rats | 2019 |
Hypoxia-induced epithelial-mesenchymal transition and fibrosis for the development of breast capsular contracture.
Topics: Animals; Breast Implants; Cell Hypoxia; Cobalt; Contracture; Epithelial-Mesenchymal Transition; Extracellular Matrix; Female; Fibronectins; Fibrosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Implant Capsular Contracture; Matrix Metalloproteinase 9; Mice; NIH 3T3 Cells; Vimentin | 2019 |
Hard metal lung disease diagnosed on a transbronchial lung biopsy following recurrent contact dermatitis.
Topics: Adrenal Cortex Hormones; Biopsy; Bronchoalveolar Lavage Fluid; Cobalt; Dermatitis, Occupational; Electron Probe Microanalysis; Fibrosis; Humans; Immunosuppressive Agents; Lung; Male; Metallurgy; Metals, Heavy; Middle Aged; Patch Tests; Pneumoconiosis; Recurrence; Smoking; Tomography, X-Ray Computed; Tungsten | 2014 |
Local tissue reaction and necrosis-induced femoral nerve palsy in a patient with a metal-on-metal total hip arthroplasty: a case report.
Topics: Adipose Tissue; Arthroplasty, Replacement, Hip; Chromium; Cobalt; Corrosion; Femoral Neuropathy; Fibrosis; Hip Prosthesis; Humans; Magnetic Resonance Imaging; Male; Metal-on-Metal Joint Prostheses; Middle Aged; Necrosis; Paralysis; Reoperation | 2014 |
Bevacizumab modulates the process of fibrosis in vitro.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antimutagenic Agents; Bevacizumab; Blotting, Western; Cell Hypoxia; Cells, Cultured; Cobalt; Connective Tissue Growth Factor; Cytokines; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Real-Time Polymerase Chain Reaction; Retinal Vessels; RNA, Messenger; Transforming Growth Factor beta2; Vascular Endothelial Growth Factor A | 2015 |
Hydrosoluble 50% N-acetylation-thiolated chitosan complex with cobalt as a pH-responsive renal fibrosis targeting drugs.
Topics: Acetylation; Animals; Biocompatible Materials; Cell Line; Chitosan; Cobalt; Drug Delivery Systems; Drug Liberation; Fibrosis; Humans; Hydrogen-Ion Concentration; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Nanoparticles; Rats; Solubility; Sulfhydryl Compounds; Ureteral Obstruction | 2016 |
All-trans retinoic acid protects renal tubular epithelial cells against hypoxia induced injury in vitro.
Topics: Animals; Blotting, Western; Carboxypeptidases; Cell Hypoxia; Cell Line; Cell Survival; Cobalt; Cytoprotection; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Epithelial Cells; Fibrosis; Gene Expression Regulation; Immunoprecipitation; Kidney Tubules, Proximal; Rats; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factor RelA; Tretinoin; Vascular Endothelial Growth Factor A | 2013 |